–
Eupraxia Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.6
FY22:
−17.6
FY23:
−27.8
FY24:
−27.0
FY25:
−38.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.3
FY22:
−17.0
FY23:
−26.8
FY24:
−25.7
FY25:
−36.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.3
FY22:
−19.0
FY23:
−28.9
FY24:
−25.7
FY25:
−38.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.0
FY22:
−18.5
FY23:
−28.2
FY24:
−25.5
FY25:
−38.6
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.